UK invests £66 million in dedicated vaccines facility

UK Research and Innovation (UKRI) has announced it will build a new Vaccines Manufacturing Innovation Centre, aimed at addressing a “structural gap in late-stage vaccine manufacturing process development.”

The center will support the development and manufacture of vaccines for clinical trials and at moderate scale to promote emergency preparedness against epidemic threats.

Chief executive Mark Walport said the facility would “play an important role in bringing expertise from industry and academia together to ensure we are prepared to respond to the threats of serious infections, including viruses with the potential to cause major national or global epidemics.”